Halozyme Therapeutics
HALO
#2469
Rank
โ‚น493.20 B
Marketcap
โ‚น3,877
Share price
-14.90%
Change (1 day)
15.95%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): โ‚น40.07 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are โ‚น0.94 Billion. In 2023 the company made an earning of โ‚น29.40 Billion, an increase over its 2022 earnings that were of โ‚น21.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น40.07 B36.27%
2023 โ‚น29.40 B39.94%
2022 โ‚น21.01 B0.16%
2021 โ‚น20.97 B92.2%
2020 โ‚น10.91 B-278.96%
2019 -โ‚น6.1 Billion-9.45%
2018 -โ‚น6.74 Billion-229.51%
2017 โ‚น5.20 B-160.48%
2016 -โ‚น8.6 Billion216.03%
2015 -โ‚น2.73 Billion-52.86%
2014 -โ‚น5.78 Billion-18.09%
2013 -โ‚น7.05 Billion55.88%
2012 -โ‚น4.53 Billion169.94%
2011 -โ‚น1.68 Billion-63.44%
2010 -โ‚น4.59 Billion-7.19%
2009 -โ‚น4.94 Billion15.91%
2008 -โ‚น4.26 Billion83.89%
2007 -โ‚น2.32 Billion78.1%
2006 -โ‚น1.31 Billion16%
2005 -โ‚น1.13 Billion45.24%
2004 -โ‚น0.78 Billion682.42%
2003 -โ‚น98.62 Million1659.12%
2002 -โ‚น5.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น1.17 B-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น856.90 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น6.34 Billion-115.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น102.32 Billion-352.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น625.36 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.552 T 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA